OakChart

Alpha Cognition Inc

ACOGHealthcare·Biotechnology·USA·Micro·NASD·Nov 12 • 3:59 PM ET

8.56-0.06 (-0.70%)
2026-11-13 13:06 CET
Market cap
$186.42M
Revenue, TTM
20.20 USD m
Net income, TTM
-29.74 USD m
Free cash flow, TTM
-30.43 USD m
EPS diluted, TTM
-1.39
Price / earnings
-
Compare

Price

ACOG against its 20, 50 and 200-day averages
Terms2050200BeatMiss
Patternshover a marker to name it
RS 41Sales 8.91Price8.168.936.008.0010.00184K367KVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ACOGclose 8.5620-day 8.5650-day 8.76200-day 7.278.5652w high 10.1452-week range, not 6 months

15.6% under the 52-week high of 10.14 on 24 Aug 2026. 52-week low 4.50 on 5 Feb 2026. Last 15 sessions, 17.2% high to low

Volume 0.00× normal · the session has not printed · the line is the 50-bar volume average

Setup. RS line 41
CANSLIM 1 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%); 52-Week High/Low: 0-10% below High; Performance: Year +50%; Average Volume: Over 200K
VCP 5 of 6 — fails: 52-Week High/Low: 0-10% below High
Minervini 2 of 4 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 1 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5
Leaders 1 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; Performance: Year +50%; Average Volume: Over 500K; 52-Week High/Low: 0-10% below High
Breakout 1 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50
Growth 1 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%); Return on Equity: Over +15%
Quality 2 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%) — not on the tape: P/E: Under 25
Value 1 of 4 — fails: P/B: Under 2; Return on Equity: Over +15% — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 2 of 4 — fails: Average Volume: Over 500K; Performance: Year +50%
Accumulation 3 of 4 — fails: Institutional Transactions: Over +10%
Relative Strength 1 of 3 — fails: Performance: Year +100%; Average Volume: Over 500K

Profile

ACOG
52-week range, 72% of the way up
4.5010.14

Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. It has additional pre-clinical development programs: ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease, ALPHA-1062 sublingual formulation, ALPHA-1062 intranasal ("ALPHA-1062IN") formulation for the treatment of cognitive impairment with mild traumatic brain injury (mTBI, otherwise known as concussion) and ALPHA-0602, ALPHA-0702 & ALPHA-0802. The company was founded in 2000 and is headquartered in Grapevine, TX.

Employees71
IPOJun 28, 2021
Beta2.33
ATR, 14d0.52
Rel volume0.00
Short float2.90%
Insider own8.37%
Inst own84.85%

Snapshot

6 groups

Valuation

Index-
Market Cap$186.42M
Enterprise Value148.56M
Income-29.74M
Sales20.20M
Book / share2.24
Cash / share1.74
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees71
IPOJun 28, 2021

Ratios

Price / earnings-
Forward price / earnings-
Price / earnings / growth-
Price / sales9.23
Price / book3.82
Price / cash4.92
Price / free cash flow-
Value / cash profit-
Value / sales7.35
Quick Ratio6.31
Current Ratio7.11
Debt / equity0.00
Long-term debt / equity0.00
Options and shortYes / Yes

Earnings

Earnings / share-1.39
Earnings next year-0.58
Earnings next quarter-0.28
Earnings this year-13.82%
Earnings next year56.45%
Earnings growth, 5 years-
Past earnings growth35.73% 45.28%
Past sales growth- -
Earnings vs last year0.11%
Sales vs last year171.93%
Earnings vs last quarter-327.08%
Sales vs last quarter173.76%
EarningsNov 11 AMC
Surprise-4.48% 10.46%

Ownership

Insiders own8.37%
Insider trades86.13%
Institutions own84.85%
Institution trades0.97%
Return on assets-53.93%
Return on equity-71.46%
Return on capital-60.30%
Gross Margin92.49%
Operating margin-149.57%
Profit Margin-147.25%
20-day average0.02%
50-day average-2.23%
200-day average17.70%

Technical

Shares out21.99M
Shares floating14.23M
Short / float2.90%
Short ratio3.22
Short interest0.41M
52-week high10.14 -15.6%
52-week low4.50 +90.2%
Volatility6.92% 6.23%
Average range0.52
Strength index48.70
Market sensitivity2.33
Relative volume0.00
Avg Volume128.06K
Volume0

Performance

Perf Week5.03%
Perf Month-1.04%
Perf Quarter-3.17%
Perf Half Y50.70%
Perf YTD31.69%
Perf Year39.87%
Perf 3Y32.67%
Perf 5Y-63.18%
Perf 10Y-
Recommendation1.20
Target Price18.20
Prev Close8.56
Price8.56
Change %0.00%

Analyst ratings

latest 5 of 5
DateActionAnalystRating changeTargetImplied
Aug 20, 2026InitiatedB. Riley SecuritiesBuy$21+145.3%
Jul 10, 2026InitiatedRaymond JamesOutperform$20+133.6%
May 29, 2026InitiatedMaxim GroupBuy$12+40.2%
Apr 17, 2026InitiatedCraig HallumBuy$14+63.6%
Mar 18, 2025InitiatedH.C. WainwrightBuy$20+133.6%

Peers

Mkt cap
TickerCompanyMkt cap
AVXLAnavex Life Sciences Corp93.62M
AXSMAxsome Therapeutics Inc7.59B
CGTXCognition Therapeutics Inc62.08M
ANVSAnnovis Bio Inc36.16M
ACADAcadia Pharmaceuticals Inc3.14B
PRTAProthena Corp Plc421.05M
INMBINmune Bio Inc34.68M
ATHEAlterity Therapeutics Ltd ADR40.01M
ALZNAlzamend Neuro Inc6.17M
SUPNSupernus Inc6.07B

Insider trading

latest 14 of 53
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Opaleye Management Inc.10% OwnerOct 22 '26Buy8.3317,117142,5263,277,011Oct 26 04:51 PM
Opaleye Management Inc.10% OwnerOct 23 '26Buy8.2314,973123,2943,291,984Oct 26 04:51 PM
Opaleye Management Inc.10% OwnerOct 15 '26Buy8.4322,657190,9743,245,611Oct 19 05:34 PM
Opaleye Management Inc.10% OwnerOct 16 '26Buy8.2314,283117,6023,259,894Oct 19 05:34 PM
Opaleye Management Inc.10% OwnerOct 01 '26Buy8.6919,050165,6343,222,954Oct 02 04:05 PM
Opaleye Management Inc.10% OwnerSep 24 '26Buy8.5718,337157,0823,190,478Sep 28 07:57 PM
Opaleye Management Inc.10% OwnerSep 25 '26Buy8.4713,426113,7183,203,904Sep 28 07:57 PM
Opaleye Management Inc.10% OwnerSep 16 '26Buy8.5180,170682,5913,172,141Sep 16 05:57 PM
Opaleye Management Inc.10% OwnerSep 14 '26Buy8.7040,373351,0843,088,596Sep 16 05:57 PM
Opaleye Management Inc.10% OwnerSep 15 '26Buy8.543,37528,8313,091,971Sep 16 05:57 PM
Wills Robert JamesDirectorAug 21 '26Buy9.6210,00096,20032,241Aug 24 02:52 PM
Opaleye Management Inc.10% OwnerAug 03 '26Buy8.0050,000400,0003,048,223Aug 04 04:50 PM
Opaleye Management Inc.10% OwnerJul 31 '26Buy7.922,90022,9762,998,223Aug 04 04:50 PM
Opaleye Management Inc.10% OwnerJul 24 '26Buy7.901301,0272,995,323Jul 28 04:05 PM

Held by

AUM
TickerCompanyAUM
AVSCAvantis U.S Small Cap Equity ETFAUM: 3.33B

News

latest 14 of 166

Quarterly earnings

2026Q3 EPS -0.350 missed -0.335, from -0.080 a year earlier. Sales 7.78 beat 7.04, from 2.80 a year earlier
EPS
0.0000-0.6502024Q4 EPS -0.510 against -0.63024Q42025Q1 EPS -0.130 against -0.58025Q12025Q2 EPS -0.650 against -0.46025Q22025Q3 EPS -0.080 against -0.43025Q32025Q4 EPS -0.313 against -0.27025Q42026Q1 EPS -0.320 against -0.38726Q12026Q2 EPS -0.400 against -0.39226Q22026Q3 EPS -0.350 against -0.33526Q3
Sales, USD millions
7.7802024Q4 sales 0.00 against 0.0024Q42025Q1 sales 2.91 against 0.5025Q12025Q2 sales 1.68 against 1.6625Q22025Q3 sales 2.80 against 2.0325Q32025Q4 sales 2.80 against 3.2025Q42026Q1 sales 3.53 against 3.4226Q12026Q2 sales 6.00 against 4.3826Q22026Q3 sales 7.78 against 7.0426Q3

The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.

PeriodReportedEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mSurpriseYear-ago quarterAnalystsNext session
2026Q3ended 2026-09-302026-11-11 16:30-0.350-0.335-0.3507.787.04EPS +4.5% · sales +10.5%vs 2025Q3, year-ago quarter · EPS +337.5% · sales +177.8%6Open 0.00% vs SPY -0.77%. Close -0.70% vs SPY -0.35%
2026Q2ended 2026-06-302026-08-13 16:30-0.400-0.392-0.4046.004.38EPS +2.0% · sales +36.9%vs 2025Q2, year-ago quarter · EPS -38.5% · sales +257.4%5Open +8.23% vs SPY +0.08%. Close +2.43% vs SPY -0.20%
2026Q1ended 2026-03-312026-05-14 16:30-0.320-0.387-0.3213.533.42EPS -17.2% · sales +3.2%vs 2025Q1, year-ago quarter · EPS +146.2% · sales +21.2%3Open +3.52% vs SPY -0.85%. Close +5.99% vs SPY -1.20%
2025Q4ended 2025-12-312026-03-26 16:30-0.313-0.270-0.3152.803.20EPS +16.0% · sales -12.5%vs 2024Q4, year-ago quarter · EPS -38.6% · sales -2Open -6.18% vs SPY -0.40%. Close -4.87% vs SPY -1.71%
2025Q3ended 2025-09-302025-11-13 16:30-0.080-0.430-0.0822.802.03EPS -81.4% · sales +37.8%vs 2024Q3, year-ago quarter · EPS -74.2% · sales -2Open -2.12% vs SPY -0.99%. Close -3.10% vs SPY -0.02%
2025Q2ended 2025-06-302025-08-14 08:30-0.650-0.460-0.6551.681.66EPS +41.3% · sales +1.3%vs 2024Q2, year-ago quarter · EPS +160.0% · sales -2Open -0.30% vs SPY -0.33%. Close -19.92% vs SPY +0.01%
2025Q1ended 2025-03-312025-05-15 08:30-0.130-0.580-0.1252.910.50EPS -77.6% · sales +482.9%-2Open +1.90% vs SPY -0.35%. Close -0.73% vs SPY +0.49%
2024Q4ended 2024-12-312025-03-31 08:30-0.510-0.630-0.5050.000.00EPS -19.0% · sales --2 EPS · 1 salesOpen -2.17% vs SPY -1.05%. Close -8.50% vs SPY +0.67%
2024Q3ended 2024-09-302024-11-15 16:30-0.310-1.000-0.3090.000.00EPS -69.0% · sales --1Open +0.56% vs SPY +0.08%. Close +6.15% vs SPY +0.41%
2024Q2ended 2024-06-302024-08-12 16:30-0.250-1.000-0.3520.000.00EPS -75.0% · sales --1Open +6.59% vs SPY +0.61%. Close +6.87% vs SPY +1.64%
2026Q4ended 2026-12-31---0.283--8.91EPS - · sales -vs 2025Q4, year-ago quarter · EPS - · sales -6-
2027Q1ended 2027-03-31---0.246--9.79EPS - · sales -vs 2026Q1, year-ago quarter · EPS - · sales -5-
2027Q2ended 2027-06-30---0.192--11.48EPS - · sales -vs 2026Q2, year-ago quarter · EPS - · sales -5-
2027Q3ended 2027-09-30---0.126--13.47EPS - · sales -vs 2026Q3, year-ago quarter · EPS - · sales -5-
2027Q4ended 2027-12-31---0.030--16.24EPS - · sales -vs 2026Q4, year-ago quarter · EPS - · sales -5-
2028Q1ended 2028-03-31--0.140--19.75EPS - · sales -vs 2027Q1, year-ago quarter · EPS - · sales -2-

Annual earnings

2025FY EPS -1.170 missed -1.115, from -2.020 a year earlier. Sales 10.22 missed 10.61, from 0.00 a year earlier
EPS
0.0000-3.7502023FY EPS -3.75020232024FY EPS -2.020 against -1.60520242025FY EPS -1.170 against -1.1152025
Sales, USD millions
10.6102023FY sales 0.00 against 0.0020232024FY sales 0.00 against 0.0020242025FY sales 10.22 against 10.612025

Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.

earnings feed, not the snapshot. Not the statement ratio.

PeriodEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mP/E, earnings feed
2030FYestimate-1.840--130.74.65
2029FYestimate-2.650--147.173.23
2028FYestimate-0.654--86.4213.09
2027FYestimate--0.580--50.66-
2026FYestimate--1.332--26.08-
2025FY-1.170-1.115-1.17510.2210.61-
2024FY-2.020-1.605-2.0400.000.00-
2023FY-3.750--3.6490.000.00-

Quarterly results

2026Q3 revenue 7.78, from 2.84 a year earlier. Operating margin -82.6%, from -186.97% a year earlier
Revenue, USD millions
7.7802024Q4 revenue 0.0024Q42025Q1 revenue 2.9325Q12025Q2 revenue 1.6625Q22025Q3 revenue 2.8425Q32025Q4 revenue 2.7925Q42026Q1 revenue 3.5326Q12026Q2 revenue 6.0926Q22026Q3 revenue 7.7826Q3
Operating margin
0.00-345.782025Q1 operating margin -125.94%25Q12025Q2 operating margin -345.78%25Q22025Q3 operating margin -186.97%25Q32025Q4 operating margin -284.23%25Q42026Q1 operating margin -229.46%26Q12026Q2 operating margin -127.42%26Q22026Q3 operating margin -82.6%26Q3

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type. 2026FY E -1.33 per share.
PeriodTypeScaleDateMeanvs prior date
2026FYEper share2026-11-12-1.33+1.0%
2026Q4Eper share2026-11-12-0.28+1.2%
2026FYRper share2026-11-12-1.35+1.8%
2026Q4Rper share2026-11-12-0.30+5.9%
2026FYSper share2026-11-1226.08+1.4%
2026Q4Sper share2026-11-128.91-1.2%
2026Q3Eper share2026-10-28-0.340.0%
2026Q3Rper share2026-10-28-0.340.0%
2026Q3Sper share2026-10-287.040.0%
2026Q2Eper share2026-08-04-0.390.0%
2026Q2Sper share2026-08-044.380.0%
2026Q2Rper share2026-07-09-0.39+0.1%
2026Q1Eper share2026-04-24-0.39+8.4%
2026Q1Sper share2026-04-243.42-16.3%
2026Q1Rper share2026-04-16-0.35-
2025FYEper share2026-03-03-1.120.0%
2025Q4Eper share2026-03-03-0.270.0%
2025FYSper share2026-02-0410.610.0%
2025Q4Sper share2026-02-043.200.0%
2025Q3Eper share2025-10-28-0.430.0%
2025Q3Sper share2025-10-172.03-32.7%
2025Q2Eper share2025-07-29-0.460.0%
2025Q2Sper share2025-07-291.660.0%
2025Q1Eper share2025-03-31-0.58+182.9%
2025Q1Sper share2025-03-310.500.0%
2024FYEper share2025-03-17-1.61+1906.3%
2024Q4Eper share2025-03-17-0.63+31.3%
2024Q4Sper share2025-03-170.00-
2024Q3Eper share2024-08-13-1.000.0%
2024Q3Sper share2024-08-130.00-
2024FYSper share2024-05-150.00-

Estimate history

Annual
Metric20182019202020212022202320242025TTMMRQ
EPS per share-0.697-2.732-24.04-9.162-4.441-3.649-2.04-1.179-1.3883-
Sales USD millions00000001020-
Shares million shares0002251622-22
Quarterly
MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
EPS per share-0.309-0.505-0.125-0.655-0.082-0.315-0.321-0.404-0.349
Sales USD millions003233468
Shares million shares61616161622222222

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202020FY7/31/20202019FY7/31/2019
Total Revenue20.2010.220.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A1.521.97+2362.5%0.080.0%0.08-11.1%0.090.0%0.09+12.5%0.080.000.00
Gross Profit18.688.25-0.08-0.08-0.09-0.09-0.080.000.00
Selling, General and Administrative Excl. Other48.8930.91+159.1%11.93+21.9%9.79-27.2%13.44+17.1%11.48+104.3%5.62+5520.0%0.07-30.0%0.10
Research and Development5.021.87-52.3%3.92-21.6%5.00-42.7%8.72+9.4%7.97+70.7%4.67--
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-30.21-22.66-12.01-9.88-13.54-11.57-5.71-0.07-0.10
Interest Expense--0.11+57.1%0.07+16.7%0.06-88.7%0.53-31.2%0.770.000.00
Unusual Expense1.42-0.09-102.8%3.16-22.9%4.10-1.82-124.3%7.50-0.670.000.00
Net Income Before Taxes-29.74-20.67-14.79-13.77-12.07-19.55-5.78-0.06-0.09
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income-29.74-20.67-14.79-13.77-12.07-19.55-5.78-0.06-0.09
Net Income From Continuing Operations-29.74-20.67-14.79-13.77-12.07-19.55-5.78-0.06-0.09
Net Income-29.74-20.67-14.79-13.77-12.07-19.55-5.78-0.06-0.09
EPS (Recurring) per share-1.34-1.18-1.73-2.89-4.91-6.70-25.99-0.06-2.73
EPS (Basic, Before Extraordinaries) per share-1.37-1.17-2.04-3.65-4.44-9.16-24.04-0.06-2.73
EPS (Diluted) per share-1.39-1.18-2.04-3.65-4.44-9.16-24.04-0.06-2.73
EBITDA-29.93-22.60-11.93-9.79-13.44-11.48-5.62-0.07-0.10
Non-Operating Income (Expense)1.891.90+387.2%0.39+39.3%0.28-0.29-680.0%0.05+150.0%0.02+100.0%0.010.0%0.01
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense5.464.92+1071.4%0.42-82.3%2.37+38.6%1.71-4.5%1.79+225.5%0.55+1275.0%0.02-50.0%0.04
Price To Sales Ratio ratio9.7411.25-------
Gross Margin %92.4980.69-------
Operating Margin %-149.57-221.72-------
Net Margin %-147.25-202.24-------
Shares Outstanding million shares21.9921.74+35.7%16.02+217.2%5.05+107.0%2.44+0.8%2.42+908.3%0.24+500.0%1.02+2450.0%0.04
Market Capitalization132.95132.95+45.3%91.48+82.2%50.21+285.0%13.04-78.3%60.00+33.2%45.06--

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Total Revenue7.78+173.9%6.09+266.9%3.53+20.5%2.792.841.662.930.00
Cost of Goods Sold Incl. D&A0.51-20.3%0.42-23.6%0.30-64.3%0.28+1300.0%0.64+3100.0%0.55+2650.0%0.84+4100.0%0.020.0%
Gross Profit7.26+230.0%5.67+410.8%3.23+55.3%2.512.201.112.08-0.02
Selling, General and Administrative Excl. Other13.69+82.3%13.43+96.1%11.33+96.4%10.44+295.5%7.51+215.5%6.85+187.8%5.77+30.2%2.64+10.9%
Research and Development1.34+135.1%2.01+528.1%1.10+168.3%0.57-45.2%0.57-43.0%0.32-67.0%0.41-55.4%1.04-9.6%
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-6.43-7.76-8.10-7.93-5.31-5.74-3.69-2.66
Interest Expense0.000.000.00-100.0%---0.01-50.0%-
Unusual Expense1.531.46-71.8%-1.12-0.44-113.3%-3.675.17-1.15-274.2%3.32-9.8%
Net Income Before Taxes-7.62-8.79-6.48-6.86-1.32-10.49-2.01-5.66
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-7.62-8.79-6.48-6.86-1.32-10.49-2.01-5.66
Net Income From Continuing Operations-7.62-8.79-6.48-6.86-1.32-10.49-2.01-5.66
Net Income-7.62-8.79-6.48-6.86-1.32-10.49-2.01-5.66
EPS (Recurring) per share-0.30-0.36-0.36-0.33-0.24-0.43-0.18-0.30
EPS (Basic, Before Extraordinaries) per share-0.35-0.40-0.30-0.32-0.08-0.65-0.13-0.51
EPS (Diluted) per share-0.35-0.40-0.32-0.32-0.08-0.65-0.13-0.51
EBITDA-6.31-7.65-8.07-7.90-5.30-5.73-3.68-2.64
Non-Operating Income (Expense)0.34+6.3%0.420.0%0.49-9.3%0.63+90.9%0.32+540.0%0.42+223.1%0.54+315.4%0.33+13.8%
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.41+31.8%1.70+9.7%1.40+2.9%0.95+1483.3%1.07+463.2%1.55+307.9%1.36+288.6%0.06-87.2%
Price To Sales Ratio ratio9.7410.3011.1213.8314.1532.5927.68-
Gross Margin %93.3893.1091.4790.0077.4567.0871.19-
Operating Margin %-82.69-127.29-229.11-283.75-186.99-346.08-125.87-
Net Margin %-97.94-144.26-183.32-245.48-46.40-632.75-68.51-
Shares Outstanding million shares21.99+35.3%21.77+35.9%21.77+35.9%21.74+35.7%16.25+169.5%16.02+166.1%16.02+167.0%16.02+217.2%
Market Capitalization132.95+31.5%112.14-22.6%85.27+8.5%100.95+10.4%101.11+67.6%144.91+90.1%78.59+7.4%91.48+82.2%

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202020FY7/31/20202019FY7/31/20192018FY7/31/2018
Cash & Short Term Investments66.11+36.1%48.56+3159.1%1.49-28.4%2.08-81.6%11.30+90.6%5.93+798.5%0.60-9.1%0.66+164.0%0.25
Short Term Receivables4.240.00-100.0%0.06+100.0%0.030.00-100.0%1.460.000.000.00
Inventories5.12+725.8%0.620.000.000.000.000.000.000.00
Other Current Assets3.32+210.3%1.07+189.2%0.37+68.2%0.22-74.7%0.87+180.6%0.310.010.00-100.0%0.01
Total Current Assets78.79+56.8%50.25+2517.2%1.92-17.6%2.33-80.9%12.17+58.1%7.70+1049.3%0.61-9.0%0.67+157.7%0.26
Net Property, Plant & Equipment0.33+1000.0%0.030.000.00-100.0%0.010.0%0.010.000.000.00
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets0.39-4.9%0.41-22.6%0.53-13.1%0.61-12.9%0.70-4.1%0.730.000.000.00
Other Assets0.22+340.0%0.050.000.000.000.000.000.000.00
Total Assets79.73+57.1%50.74+1971.0%2.45-16.9%2.95-77.1%12.88+52.6%8.44+1159.7%0.61-9.0%0.67+157.7%0.26
Short Term Debt Incl. Current Port. of LT Debt0.00-100.0%0.91-25.4%1.22+0.8%1.21+12.0%1.08+5300.0%0.020.000.000.00
Accounts Payable3.070.000.000.000.000.000.000.000.00
Other Current Liabilities6.06+148.4%2.44+74.3%1.40-50.9%2.85+290.4%0.73-79.4%3.55+11733.3%0.030.0%0.030.0%0.03
Total Current Liabilities9.13+172.5%3.35+27.9%2.62-35.5%4.06+125.6%1.80-49.7%3.58+11833.3%0.030.0%0.030.0%0.03
Long Term Debt0.000.000.000.000.00-100.0%3.190.000.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities8.07-2.7%8.29+82.6%4.54+2061.9%0.21-89.8%2.05+24.2%1.650.000.000.00
Total Liabilities17.20+47.8%11.64+62.6%7.16+67.7%4.27+10.9%3.85-54.3%8.42+27966.7%0.030.0%0.030.0%0.03
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity62.53+60.0%39.09-4.71-1.32-114.6%9.03+45050.0%0.02-96.8%0.58-7.9%0.63+173.9%0.23
Total Shareholders Equity62.53+60.0%39.09-4.71-1.32-114.6%9.03+45050.0%0.02-96.8%0.58-7.9%0.63+173.9%0.23
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity62.53+60.0%39.09-4.71-1.32-114.6%9.03+45050.0%0.02-96.8%0.58-7.9%0.63+173.9%0.23
Total Liabilities & Stockholders Equity79.73+57.1%50.74+1971.0%2.45-16.9%2.95-77.1%12.88+52.6%8.44+1159.7%0.61-9.0%0.67+157.7%0.26
Book Value Per Share per share2.88+18.0%2.44-0.93-0.54-114.5%3.72+5214.3%0.07-99.5%0.57-96.3%15.52+220.7%4.84
Tangible Book Value Per Share per share2.86+18.7%2.41-1.04-0.79-123.0%3.44-2.96-119.1%0.57-96.3%15.52+220.7%4.84
Full-Time Employees people71+24.6%57+1040.0%5-16.7%6-33.3%9-52.6%19---
Price to Book Ratio ratio3.82-12.17-8.187.356.6431.67---
Return on Assets %-31.69-55.61-509.80-152.52-183.38-127.10-9.83-19.50-
Return on Equity %-39.75-86.03--313.21-432.14-1,785.27-10.33-20.83-
Return on Invested Capital %-33.06-37.83---216.46-180.36-10.83-14.22-14.36
Quick Ratio ratio8.0714.810.730.586.752.1521.1819.7910.12
Current Ratio ratio8.6315.000.730.586.752.1521.1819.7910.12

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202020FY7/31/20202019FY7/31/2019
Net Income-28.26-20.67-14.79-13.77-12.07-19.55-5.78-0.06-0.09
Depreciation0.280.06-25.0%0.080.0%0.08-11.1%0.090.0%0.09+12.5%0.08--
Other Funds (Non Cash)6.084.85-32.5%7.19+11.5%6.450.00-100.0%9.77+1555.9%0.59+1375.0%0.02-50.0%0.04
Funds from Operations-21.90-15.76-7.51-7.24-11.98-9.68-5.11-0.05-0.05
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-8.10-4.62-0.24-1.56-157.1%2.73-0.20-0.33-3400.0%-0.01-200.0%0.01
Cash from Operating Activities-30.00-20.38-7.76-8.80-9.25-9.88-5.44-0.06-0.04
Capital Expenditures-6.27-0.29-0.030.00-0.00-0.06-0.010.000.00
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.00-100.0%0.520.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-6.27-0.29-0.030.00-0.00-100.0%0.46-0.010.000.00
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock39.2039.09-23.6%51.14+524.4%8.19+20375.0%0.04-99.7%14.90+684.2%1.90+322.2%0.00-100.0%0.45
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock39.2039.09-23.6%51.14+524.4%8.19+20375.0%0.04-99.7%14.90+684.2%1.90+322.2%0.00-100.0%0.45
Proceedsfrom Stock Options37.4137.70-25.8%50.84+522.3%8.170.00-100.0%12.46+555.8%1.90+322.2%0.00-100.0%0.45
Issuance or Reduction of Debt, Net0.01-0.91-124.0%3.790.000.00-0.02-100.5%3.980.000.00
Change in Long Term Debt0.000.00-100.0%4.090.000.000.000.000.000.00
Issuance of Long Term Debt0.000.00-100.0%4.090.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.000.04-0.07-275.0%0.040.000.000.000.000.00
Other Financing Activities Uses0.00-0.13-0.45-0.170.000.000.000.000.00
Cash from Financing Activities39.2138.21-30.3%54.85+566.5%8.23+20475.0%0.04-99.7%14.88+153.1%5.88+1206.7%0.00-100.0%0.45
Exchange Rate Effect--0.00-0.02-0.00-0.08---
Net Change in Cash2.9417.54-62.7%47.07-0.59-9.22-271.4%5.38+1151.2%0.43+4.9%-0.05-112.2%0.41
Free Cash Flow-30.43-20.67-7.78-8.80-9.26-9.89-5.45-0.06-0.04
Preferred Dividends (Cash Flow)---0.000.000.00-0.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Cash & Short Term Investments37.86+6.8%41.44+5.0%54.31+19.0%66.11+36.1%35.46+840.6%39.46+3216.0%45.62+1785.1%48.56+3159.1%
Short Term Receivables6.98+135.0%5.47+180.5%3.58+486.9%4.24+1596.0%2.97+14750.0%1.95+3800.0%0.61+510.0%0.25+316.7%
Inventories6.41+42.4%6.39+626.1%6.04+586.4%5.12+725.8%4.500.880.880.62
Other Current Assets5.86+111.6%4.39+86.8%4.41+341.0%3.32+304.9%2.77+284.7%2.35+770.4%1.00+203.0%0.82+121.6%
Total Current Assets57.12+25.0%57.70+29.2%68.33+42.0%78.79+56.8%45.70+913.3%44.65+2857.0%48.12+1588.4%50.25+2517.2%
Net Property, Plant & Equipment0.52+160.0%0.37+428.6%0.31+342.9%0.33+1000.0%0.200.070.070.03
Total Investments and Advances0.000.000.000.000.000.000.000.00
Intangible Assets6.13+1432.5%6.22+1455.0%0.39-4.9%0.39-4.9%0.40-7.0%0.40-11.1%0.41-12.8%0.41-22.6%
Other Assets0.220.220.22+2100.0%0.22+340.0%0.00-100.0%0.00-100.0%0.01-93.3%0.05
Total Assets64.00+38.2%64.52+43.0%69.25+42.5%79.73+57.1%46.30+820.5%45.12+2069.2%48.61+1296.8%50.74+1971.0%
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.00-100.0%0.00-100.0%0.00-100.0%0.00-100.0%0.91-25.4%
Accounts Payable0.83-1.2%1.19+58.7%1.43+74.4%3.070.840.750.820.00
Other Current Liabilities7.21+20.4%5.22+127.9%3.99+100.5%6.06+148.4%5.99+234.6%2.29+80.3%1.99+109.5%2.44+74.3%
Total Current Liabilities8.04+17.7%6.41+110.9%5.43+93.2%9.13+172.5%6.83+126.9%3.04+93.6%2.81+30.1%3.35+27.9%
Long Term Debt0.000.000.000.000.00-100.0%0.00-100.0%0.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Other Liabilities6.64+19.4%5.15-49.5%6.37+27.7%8.07+36.3%5.56+120.6%10.19+929.3%4.99+341.6%5.92+30.4%
Total Liabilities14.68+18.5%11.56-12.6%11.79+51.2%17.20+85.5%12.39+55.8%13.23+280.2%7.80+137.1%9.27+29.5%
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity49.32+45.4%52.96+66.0%57.46+40.8%62.53+50.8%33.9131.9040.81+22572.2%41.46
Total Shareholders Equity49.32+45.4%52.96+66.0%57.46+40.8%62.53+50.8%33.9131.9040.81+22572.2%41.46
Accumulated Minority Interest0.000.000.000.000.000.000.000.00
Total Equity49.32+45.4%52.96+66.0%57.46+40.8%62.53+50.8%33.9131.9040.81+22572.2%41.46
Total Liabilities & Stockholders Equity64.00+38.2%64.52+43.0%69.25+42.5%79.73+57.1%46.30+820.5%45.12+2069.2%48.61+1296.8%50.74+1971.0%
Book Value Per Share per share2.24+7.2%2.43+22.1%2.64+3.5%2.88+11.2%2.091.992.55+8400.0%2.59
Tangible Book Value Per Share per share1.96-4.9%2.15+9.1%2.62+4.0%2.86+11.7%2.061.972.522.56
Full-Time Employees people---71+24.6%---57+1040.0%
Price to Book Ratio ratio3.822.741.913.113.273.661.96-12.17
Return on Assets %-53.93-42.76-42.66-31.69-75.87-84.80-44.70-55.04
Return on Equity %-71.46-55.25-51.17-39.75-125.65-131.23-56.79-79.66
Return on Invested Capital %-15.44-16.60-11.27-10.96-3.89-32.88-4.92-13.65
Quick Ratio ratio6.318.0011.488.076.0314.4016.8314.81
Current Ratio ratio7.119.0012.608.636.6914.6917.1415.00

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Net Income-6.38-8.72-6.48-6.69-1.31-10.71-2.01-5.38
Depreciation0.12+1100.0%0.10+900.0%0.03+200.0%0.03+50.0%0.01-50.0%0.01-50.0%0.01-50.0%0.020.0%
Other Funds (Non Cash)2.923.13-55.0%-0.31-219.2%0.34-89.8%-2.70-1787.5%6.96+3994.1%0.26-92.0%3.34-16.5%
Funds from Operations-3.34-5.49-6.76-6.32-4.00-3.74-1.74-2.03
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital-1.35-1.29-5.04-0.42-1.36-1336.4%-2.54-608.0%-0.31-0.13
Cash from Operating Activities-4.69-6.77-11.80-6.74-5.35-6.28-2.04-2.16
Capital Expenditures-0.15-5.98-0.00-0.15-0.08-0.01-0.06-0.03
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities-0.15-5.98-0.00-0.15-0.08-0.01-0.06-0.03
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.00---0.00---
Change in Capital Stock1.43+3.6%-0.00-100.0%0.0037.76-18.8%1.38+820.0%0.03-78.6%0.00-100.0%46.48+1667.3%
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00
Sale of Common Pref Stock1.43+3.6%-0.00-100.0%0.0037.76-18.8%1.38+820.0%0.03-78.6%0.00-100.0%46.48+1667.3%
Proceedsfrom Stock Options0.00-100.0%0.000.0037.41-19.0%0.37+146.7%0.00-100.0%0.00-100.0%46.18+1662.6%
Issuance or Reduction of Debt, Net0.000.000.000.010.00-100.0%-0.02-0.91-0.37
Change in Long Term Debt0.000.000.000.000.00-100.0%0.000.00-0.07
Issuance of Long Term Debt0.000.000.000.000.00-100.0%0.000.00-0.07
Reduction of Long Term Debt0.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.00-100.0%-0.00-0.00-0.04-500.0%0.08+14.3%-0.09
Other Financing Activities Uses0.000.000.000.000.00-0.04-0.10-0.08
Cash from Financing Activities1.43+3.6%-0.000.0037.77-17.9%1.38-66.8%-0.03-120.0%-0.83-124.4%46.02+1726.2%
Exchange Rate Effect-------0.00
Net Change in Cash-3.40-12.75-11.8030.89-29.5%-4.05-257.6%-6.32-2.94-416.1%43.84+7206.7%
Free Cash Flow-4.87-6.87-11.80-6.89-5.43-6.29-2.11-2.19

Revenue breakdown

USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.

Product
Name20252025 share
Biological Products, (No Diagnostic Substances)10.22100.0%
Total10.22100.0%
Region
Name20252025 share
China3.4333.5%
United States6.7966.5%
Total10.22100.0%

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.90%0.4M14.2M121.87K
2026-10-152.48%0.4M14.2M125.28K
2026-09-302.27%0.3M14.2M121.90K
2026-09-151.47%0.2M14.2M111.47K
2026-08-311.49%0.2M14.2M99.97K
2026-08-141.44%0.2M14.2M69.95K
2026-07-311.30%0.2M14.2M60.46K
2026-07-151.52%0.2M14.2M45.57K
2026-06-300.91%0.1M14.2M50.53K
2026-06-151.23%0.2M14.2M48.17K
2026-05-291.28%0.2M13.9M52.17K
2026-05-151.36%0.2M13.9M59.89K
2026-04-301.34%0.2M13.4M68.75K
2026-04-151.58%0.2M13.0M71.49K
2026-03-312.52%0.3M13.0M67.78K
2026-03-132.57%0.3M13.0M77.70K
2026-02-272.45%0.3M13.0M83.95K
2026-02-131.76%0.2M13.0M81.28K
2026-01-302.59%0.3M13.0M86.90K
2026-01-152.28%0.3M13.0M94.76K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.503.708.500.000.0000.000.000.944-0.1130.001
call5.001.606.000.0010.8920.000.000.856-0.1180.003
call7.500.004.900.009.9650.000.000.709-0.0880.004
call10.000.000.400.201.2825480.000.233-0.0320.004
call12.500.004.901.592.6662.000.000.237-0.0660.004
call15.000.004.900.053.40216.000.000.203-0.0780.004
call17.500.004.900.003.9670.000.000.184-0.0850.003
put2.500.003.600.0012.4420.000.00-0.056-0.1130.001
put5.000.004.900.006.3050.000.00-0.145-0.1150.003
put7.500.001.000.753.0311.000.00-0.297-0.0790.005
put10.000.204.900.008.2030.000.00-0.672-0.0470.005
put12.501.906.500.007.3260.000.00-0.842-0.0410.003
put15.004.309.000.008.2740.000.00-0.797-0.0770.004
put17.506.6011.500.008.8070.000.00-0.883-0.0510.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-128-KCurrent report2026-11-05SEC
2026-11-1210-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-264Statement of changes in beneficial ownership of securities2026-10-22SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-24SEC
2026-09-23SCHEDULE 13GSEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-08-244Statement of changes in beneficial ownership of securities2026-08-21SEC
2026-08-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-07-31SEC
2026-07-284Statement of changes in beneficial ownership of securities2026-07-24SEC
2026-07-24SCHEDULE 13G/ASEC
2026-07-244Statement of changes in beneficial ownership of securities2026-07-22SEC
2026-06-29SCHEDULE 13G/ASEC
2026-06-294Statement of changes in beneficial ownership of securities2026-06-25SEC
2026-06-238-KCurrent report2026-06-16SEC
2026-06-154Statement of changes in beneficial ownership of securities2026-06-11SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-094Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-27SEC
2026-05-22SCHEDULE 13G/ASEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-12SCHEDULE 13G/ASEC
2026-05-11SCHEDULE 13G/ASEC
2026-05-018-K/A2026-04-15SEC
2026-04-30DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-10740.03K500
2026-091.33M500
2026-08496.20K200
2026-071.59M400
2026-061.26M800
2026-05791.43K800
2026-040000
2026-031.10M1600
2026-021.03M500
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Opaleye Management Inc.18.64%
Solas Capital Management, LLC12.39%
AWM Investment Company, Inc.10.77%
Cable Car Capital, LP8.90%
Ikarian Capital, LLC5.38%
SPHERA FUNDS MANAGEMENT LTD.3.51%
ESSEX INVESTMENT MANAGEMENT CO LLC2.72%
Alyeska Investment Group, L.P.2.35%
Aristides Capital LLC1.41%
CANTOR FITZGERALD, L. P.1.40%

Funds

Fund% owned
Fidelity Nasdaq Composite Index Fund0.09%
Avantis U.S. Small Cap Equity ETF0.03%

OakChart. ACOG. Cached 15 minutes. Terms